2025 Healthcare Manufacturing Medical 
Alabama Academy of Family Physicians
MAY 15, 2025
The 2025 Alabama Legislative Session concluded on May 14 at midnight. During the session, the Alabama Academy of Family Physicians actively represented the interests of its members on a range of healthcare initiatives. What Happened: The bill was signed into law by the Governor on 4/15/2025.
My Green Doctor
MAY 3, 2025
In This Issue : Why Renewable Energy Belongs in Every Clinic Medical Waste: One Model for Improvement OnTrack with your Sustainability Goals? Powering Health, Protecting the Planet – Why Renewable Energy Belongs in Every Clinic Healthcare professionals have always been trusted voices on public health.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Physician's Weekly
JUNE 18, 2025
Cost-sharing interventions and patient education can help improve access to GLP-1 receptor agonists for patients with obesity, according to an abstract presented at the AACE Annual Meeting 2025. The patient was enrolled in a cost-sharing program that reduced her out-of-pocket expenses by 70%, allowing her to access the medication.
FDA Law
SEPTEMBER 22, 2024
MDR FDA discussed a few preliminary steps that it says laboratories should take prepare for submitting MDRs as medical device manufacturers. SCF : LDT, unmet need within an integrated healthcare system. SCG : Modified version of another manufacturer’s FDA-authorized test within scope described in preamble to LDT Final Rule.
Physician's Practice
JUNE 9, 2025
of Roetzel & Andress June 9, 2025 By Austin Littrell Fact checked by Keith A. a health care attorney with Roetzel & Andress, joins the show to explore the legal risks of prescribing GLP-1 medications. Austin Littrell June 2nd 2025 Podcast Tom Price, M.D., 68: Hidden risks of prescribing GLP-1 drugs with Ericka L.
FDA Law
MAY 7, 2025
Gonzalez There has been increased enforcement against medical device companies that engage in the pervasive practice of paying third party sales agents based on their volume of sales. Walsh & Sophia R. Gaulkin & Steven J. This scrutiny was enhanced after the Fourth Circuits ruling in United States v. Mallory , 988 F.3d
FDA Law
JANUARY 5, 2025
In response to the proposed rule, approximately 200 comments were submitted to the docket, and a meeting took place among FDA, the White House Office of Management and Budget (OMB) and the Consumer Healthcare Products Association (CHPA). The final rule becomes effective on January 27, 2025.
Expert insights. Personalized for you.
130 
Let's personalize your content